Reports without reliable country information are labeled as country not specified. PulseGLP analyzed 90 relevance-ranked patient reports across GLP-1, Ozempic, Mounjaro from r/GLP1, r/Ozempic, r/Mounjaro. The strongest structured pattern in this sample is symptom: Other, appearing in 18 extracted reports. The matching posts skew Neutral-Low, Risk-Alert, Analytical. This is a matched-sample finding, not a population-wide prevalence estimate.
Share of structured matched reports; this is not a population prevalence estimate.
Patient reports vary widely; ask your prescriber before changing dose, stopping medication, or treating persistent symptoms.
"CVS is adding Zepbound back to its formulary effective October 1 Huge news for those who lost coverage."
Patient · GLP-1 · r/GLP1 · United States
"This is because Reta isn’t yet FDA approved so most taking it aren’t obese nor are the studies out there yet. It doesn’t suggest Reta is different. Reta is more powerful so tends to have more effects."
Patient · Retatrutide · r/Retatrutide · United States
"This is because Reta isn’t yet FDA approved so most taking it aren’t obese nor are the studies out there yet. It doesn’t suggest Reta is different. Reta is more powerful so tends to have more effects."
Patient · Retatrutide · r/Retatrutide · United States
"This sound right? I've had retatrutide sitting in my fridge for 3 days now because I'm scared to use it. I'm more so worried about long term side effects or buying something that is not what it claims to be."
Patient · Retatrutide · r/Retatrutide · United States
Sourced from GLP-1 patient communities · See community discussion →
Published: · Updated: